Skip to main content
. 2005 Nov 8;93(11):1215–1221. doi: 10.1038/sj.bjc.6602858

Table 3. Two hypothetical treatments (A and B).

Percentage of patients with a complete/partial tumour response Median survival, months (95% CI) Percentage of patients with progressive disease Median survival, months (95% CI) Median time to progression (months) Median survival, months (95% CI)
On treatment A On treatment A On treatment A
30 20 12 20 10 20
           
On treatment B On treatment B On treatment B
40 22 (20–24) 10 21 (20–22) 12 23 (21–24)
50 25 (22–28) 8 22 (20–23) 16 26 (23–29)
60 28 (24–33) 6 23 (21–25) 20 29 (25–34)

The estimated effect on survival using treatment B compared to A based on arbitrary estimates of tumour response and disease progression, and the regression analyses in Figure 1.

CI, confidence interval (based on the 95% CI of the predicted mean value in the regression analysis).